KalVista Pharmaceuticals, Inc.'s latest moves, explained simply — so you know why the numbers change.
Straight from SEC filings · updated 6 Aug 2026When a company merges and stops trading publicly, you can no longer buy or sell its shares easily.
Quarterly reports show if a company is making money and how its business is doing.
When another company buys yours, shareholders get paid, and the business operates under new ownership.
Companies announce quarterly earnings to update investors on sales, profits, and business performance.
Stocky reads KalVista Pharmaceuticals, Inc.'s official filings with the U.S. Securities and Exchange Commission (SEC) — the 8-K, 10-Q and 10-K reports every public company must file — and summarizes each one in plain English, with a link back to the original document.
KalVista Pharmaceuticals, Inc.'s most recent tracked filing was a 8-K on 11 Jun 2026: Merger with Chiesi completed, stock delisted from Nasdaq.
No. These event summaries are educational — generated from public SEC filings to help beginners understand what a company is doing. They are not buy or sell recommendations.
Educational, not financial advice. Company events summarized from public SEC filings.
Data as of 6 Aug 2026.